National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

bispecific antibody MDX447
An antibody with potential antineoplastic activity. Specific for both the high-affinity immunoglobulin G (IgG) receptor CD64 and epidermal growth factor receptor (EGFR), bispecific antibody MDX447 may enhance cellular immune responses against EGFR positive cells, resulting in increased tumor cell lysis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:BsAb MDX447
Code names:EMD 82633
MDX-447



Previous:bismuth Bi213 monoclonal antibody M195, bismuth subsalicylate, bispecific antibody 2B1, bispecific antibody 4G7xH22, bispecific antibody MDX-H210
Next:bizelesin, BL22 immunotoxin, black cohosh, black tea, Blenoxane

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov